Astal Laboratories Ltd Share Price

Q: What is the share price of Astal Laboratories Ltd today?

Astal Laboratories Ltd share price as on 24 Jun 2026 is ₹77.25

Pharmaceuticals

BSE: 512600 Small Cap ISIN: INE307N01014

As on 24 June 2026 at 22:34 IST

₹77.25

-0.51

(-0.66%)

Sell Buy

Over 1 Month

-9.56%

Over 6 Months

-7.20%

Over 1 Year

-8.99%

Over 3 Years

154.95%

Astal Laboratories Ltd Summary

Close ₹77.76

Open ₹72

High ₹78.90

Low ₹72

Volume 75,780

Net Turnover (in Cr) ₹0.57

52Wk High ₹103.20

52Wk Low ₹60.45

52Wk High / Low

60.45

103.20

Astal Laboratories Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹340.58

EPS (TTM) 1.85

Book Value (BV) 76.14

Div. Yield -

P/E (TTM) 42.03

Price/Book Value 1.02

Delivery % 58.56 %

Face Value 10

Key Ratios

PE Ratio 8.38

PB Ratio 2.32

EV to Sales 1.34

PEG Ratio 0.01

ROA 18.13

ROE 30.10

Debt-Equity 0.23

Net Profit Margin 13.90

Operating Profit Margin 20.08

Astal Laboratories Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	64.36	23.66	3.61	0.21	0.20
Total Expenses	52.38	22.57	3.57	0.23	0.19
Profit Before Tax	11.98	1.09	0.03	-0.02	0.01
Profit After Tax	8.93	0.78	0.02	-0.02	0.01
Operating Profit After Depreciation	12.68	1.10	0.03	-0.02	0.01

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	11.44	0.69	0.01	0.01	0.05
Total Non Current Assets	17.70	9.89	3.79	5.13	5.19
Total Current Assets	45.64	26.73	6.11	0.10	0.11
Total Assets	63.34	36.61	9.91	5.23	5.31
Total Shareholder's Fund	35.99	23.34	5.18	5.16	5.18

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-12.52	-5.58	-1.44	-0.25	-0.19
Net Cash Used In Investing Activities	-7.81	-6.11	1.50	0.24	0.20
Net Cash Used In Financing Activities	3.29	17.68	-	-	-

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-03
Total Revenue	134.05	52.24	23.47
Total Expenses	123.86	48.69	19.29
Profit Before Tax	8.34	3.14	3.85
Profit After Tax	7.68	2.36	2.74
Operating Profit after Depreciation	10.29	3.59	4.22

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	40.92	52.24	37.52	25.33	23.47
Total Expenses	38.72	48.69	33.65	22.17	19.29
Profit Before Tax	1.48	3.14	3.47	2.80	3.85
Profit After Tax	1.09	2.36	2.58	2.09	2.74
Operating Profit after Depreciation	2.27	3.59	3.90	3.22	4.22

Astal Laboratories Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 73.54

S2 69.32

S3 66.64

Pivot 76.22

R1 80.44

R2 83.12

R3 87.34

Moving Average

20 SMA 74.04

50 SMA 70.95

100 SMA 74.46

200 SMA 81.48

Astal Laboratories Ltd Corporate Actions

No available data

AGM Date: 27 Sep 2021

Notice of 28th Annual General Meeting of the Company Outcome of Board Meeting held on 01/09/2021 Proceedings of the 28th Annual General meeting of the Company held on 27th September ,2021 (As per BSE Announcement Dated on 27/09/2021) Details of Voting Result of the 28th Annual General meeting held on 27th September2021 of the Company (As Per BSE Announcement Dated on 9/28/2021 6:11:45 AM)

AGM Date: 30 Sep 2022

AGM 30/09/2022 Outcome of Board meeting held on 08.09.2022 for approve the Notice for 29 the Annual General meeting of the Company (As Per BSE Announcement Dated 08.09.2022) GIST of the Proceeding of 29th Annual General meeting of the Company (As Per BSE Announcement dated on 30.09.2022) Voting Results of the 29th Annual general meeting of the company held on 30th september,2022 (As Per BSE Announcement Dated 02.10.2022) Appointment of Statutory Auditor of the Company (As Per BSE Announcement Dated 06.10.2022)

AGM Date: 18 Sep 2023

AGM 18/09/2023 Outcome of 30th Annual General Meeting (AGM) held on Monday September 18, 2023. (As Per BSE Announcement dated on 18.09.2023) Shareholders Meeting- Voting results and Scrutinizer''s Report. Shareholder Meeting- Scrutinizer''s Report. Change in designation of directors of the Company. (As Per BSE Announcement Dated on 20/09/2023)

AGM Date: 05 Aug 2024

The 31st Annual General Meeting of the Company to be convened on, Monday, 5th August 2024 at 03:00 P.M., through Video Conferencing/ Other Audio Visual Means (OAVM). Submission of Proceedings of 31st Annual General Meeting. (As per BSE Announcement Dated on 05/08/2024) Submission of Voting Result of 31st Annual General Meeting. (As Per BSE Announcement Dated on: 06/08/2024)

AGM Date: 12 Sep 2025

Submission of intimation of Book Closure. Annual Report for the financial year 31st March, 2025. (As Per BSE Announcement Dated on: 18/08/2025) Submission of the outcome of 32nd Annual General meeting. (As Per BSE Announcement Dated on:12.09.2025) Submission of voting Results and Scrutinizer''s Report. (As Per Bse Announcement dated on 13/09/2025)

EGM Date: 19 Jan 2023

Board of Directors at its meeting held on Friday, 23rd December, 2022 at 3:00 P.M. has Authorized to open a corporate office, Approved the Notice of EGM, Cut-Off Date, remote e-voting period, 5. Appoint Scrutinizer, Appointed CEO, Appointed COO, Adopted a new set of Memorandum of Association (MOA) of the Company as per the Companies Act, 2013, Re-constituted Audit Committee, Nomination & Remuneration Committee, Stakeholders Relationship Committee, Authorized to Open Banking Accounts, Authorized to take all statutory approvals Notice of First Extra Ordinary General Meeting of the Company for the financial year 2022-2023 to be held on Thursday, 19th Jaunuary, 2023 at 11:00 A.M. at the corporate office of the company at 304, 3rd Floor, Babukhan Estates, Basheerbagh, Hyderabad 500001 Telangana IN. 1. Extra-Ordinary General Meeting of the Company will be held on Thursday, 19th Jaunuary, 2023 at 11:00 A.M at the corporate office of the company at 304, 3rd Floor, Babukhan Estates, Basheerbagh, Hyderabad 500001 Telangana IN. 2. The Board has fixed Thursday, 12th January 2023 as the 'Cut-Off Date' for determining eligibility of the members to vote by electronic means or at the Extra-Ordinary General Meeting. 3. The remote e-voting period shall commence from 16th January, 2023 (10:00 A.M.) and ends on 18th January, 2023 (5:00 P.M.). (As per BSE Announcement Dated on 24/12/2022) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the gist of the proceedings of the Extra Ordinary General Meeting of the company held on 19th January, 2023. (As Per BSE Announcement Dated on 19/01/2023) In continuation to our Outcome of Extra Ordinary General Meeting of the company held on 19th January, 2023, please find attached herewith a new set of Memorandum of Association (MOA) of the Company as per the Companies Act, 2013 adopted in the Extra Ordinary General Meeting Details of Voting Results of the Extra Ordinary General Meeting of the Members of the Company held on Thursday, 19th January, 2023 at 11.00 A.M as per the requirements of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and COMBINED SCRUTINIZER REPORT FOR E-VOTING & POLL (As per BSE Announcement Dated on 20/01/2023)

EGM Date: 06 Nov 2025

Submission of outcome of Board meeting. EGM Intimation Submission of intimation of EGM Cut off date & remote e-voting (As Per Bse Announcement dated on 10/10/2025) Submission of Notice of Extra Ordinary General Meeting. (As Per BSE Announcement Dated On : 13.10.2025) Submission of intimation of corrigendum to the EGM Notice. (As Per BSE Announcement Dated on:05.11.2025) Submission of Outcome of the EGM. (As Per BSE Announcement Dated on 05.11.2025) Submission of Outcome of the EGM. (As Per BSE Announcement Dated on: 06/11/2025) Submission of Intimation of Voting results and Scrutinizer''s Report. (As Per BSE Announcement Dated on:07.11.2025)

Astal Laboratories Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Astal Laboratories Ltd Top Mutal Funds Invested

No data available

Astal Laboratories Ltd News

Astal Laboratories to convene board meeting

On 30 May 2026

26 May 2026, 01:59 pm

Astal Laboratories to conduct board meeting

On 14 February 2026

11 Feb 2026, 10:22 am

Astal Laboratories to declare Quarterly Results

On 14 November 2025

12 Nov 2025, 04:09 pm

Astal Laboratories to conduct EGM

On 6 November 2025

13 Oct 2025, 05:01 pm

Astal Laboratories to conduct board meeting

On 9 October 2025

04 Oct 2025, 10:06 am

Astal Laboratories Ltd Stock Analysis

Annual revenue for Astal Laboratories Ltd increased by 171.99% to ₹64.36 crore in FY 2025 from ₹23.66 crore in FY 2024.
Annual Net Profit for Astal Laboratories Ltd increased by 1037.42% to ₹8.93 crore in FY 2025 from ₹0.78 crore in FY 2024.
Promoter Shareholding in Astal Laboratories Ltd increased by 0.26% in the most recent quarter, from 4.53% in May 2026 to 4.55% in May 2026.
Astal Laboratories Ltd delivered a 1-year return of -8.99% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Astal Laboratories Ltd share price moved down by 0.66% from its previous close of INR ₹77.76. The latest Astal Laboratories Ltd share price is INR ₹77.25.
Astal Laboratories Ltd share price today has been at a low of 77 and a high of 81. Over the past 52 weeks, the Astal Laboratories Ltd share price has seen a low of 60.45 and a high of 103.20.